Cite
HARVARD Citation
Loomes, K. et al. (2022). Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study. Hepatology communications. 6 (9), pp. 2379-2390. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Loomes, K. et al. (2022). Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study. Hepatology communications. 6 (9), pp. 2379-2390. [Online].